An open-label, parallel-group, randomised controlled trial of antiseptic mouthwash versus antibiotics for oropharyngeal gonorrhoea treatment (OMEGA2)

New treatments for oropharyngeal gonorrhoea are required to address rising antimicrobial resistance. We aimed to examine the efficacy of a 14-day course of mouthwash twice daily compared to standard treatment (antibiotic) for the treatment of oropharyngeal gonorrhoea. The OMEGA2 trial was a parallel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Eric P. F., Maddaford, Kate, Hocking, Jane S., Bradshaw, Catriona S., Wigan, Rebecca, Chen, Marcus Y., Howden, Benjamin P., Williamson, Deborah A., Fairley, Christopher K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652834/
https://www.ncbi.nlm.nih.gov/pubmed/33168910
http://dx.doi.org/10.1038/s41598-020-76184-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652834/
https://www.ncbi.nlm.nih.gov/pubmed/33168910
http://dx.doi.org/10.1038/s41598-020-76184-1

Ejemplares similares